Literature DB >> 15140611

Nonparaneoplastic limbic encephalitis with relapsing polychondritis.

Yasuyuki Ohta1, Isao Nagano, Daigo Niiya, Hideki Fujioka, Takumi Kishimoto, Mikio Shoji, Koji Abe.   

Abstract

Relapsing polychondritis (RP), which shows pain, swelling and destruction of the affected parts, is a rare autoimmune disorder affecting cartilage. We report a patient with RP that affected skull cartilage, who subsequently developed multifocal meningoencephalitis. The patient presented with severe recent memory disturbance, anxiety and moderate depression. MRI study showed bilateral median temporal lobe lesions including hippocampi and amygdaloidal bodies, abnormal findings that disappeared after treatment with high-dose steroids. This is thought to be the first case of RP presenting amnesic syndrome and mental disorder associated with nonparaneoplastic limbic encephalitis involving bilateral hippocampi and amygdaloidal bodies detected by MRI.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15140611     DOI: 10.1016/j.jns.2004.02.010

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  10 in total

1.  Unusual association of seronegative, nonparaneoplastic limbic encephalitis and relapsing polychondritis in a patient with history of thymectomy for myasthenia: a case study.

Authors:  Kateřina Storey; Radoslav Matěj; Robert Rusina
Journal:  J Neurol       Date:  2010-08-13       Impact factor: 4.849

2.  Relapsing polychondritis: an uncommon cause of dementia.

Authors:  D Erten-Lyons; B Oken; R L Woltjer; J Quinn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-01-21       Impact factor: 10.154

3.  "Prominent ear sign" on diffusion-weighted magnetic resonance imaging in relapsing polychondritis.

Authors:  Masatomo Kuwabara; Taro Shimono; Mami Toyomasu; Mitsuaki Shioyama; Yoshiyuki Mitsui; Eiji Yoshinaga; Akira Kawada; Makoto Hosono; Takamichi Murakami; Susumu Kusunoki
Journal:  Radiat Med       Date:  2008-09-04

4.  Relapsing polychondritis: an uncommon cause of dementia.

Authors:  Deniz Erten-Lyons; Barry Oken; Randall L Woltjer; Joseph Quinn
Journal:  BMJ Case Rep       Date:  2009-02-02

Review 5.  Relapsing polychondritis: a chameleon among orphan diseases.

Authors:  Sabine Schumacher; Herwig Pieringer
Journal:  Wien Med Wochenschr       Date:  2017-03-31

6.  Limbic encephalitis associated with relapsing polychondritis responded to infliximab and maintained its condition without recurrence after discontinuation: a case report and review of the literature.

Authors:  Takeshi Kondo; Mamiko Fukuta; Ayumu Takemoto; Yuichiro Takami; Motoki Sato; Noriyuki Takahashi; Tomio Suzuki; Juichi Sato; Naoki Atsuta; Gen Sobue; Yukitoshi Takahashi; Nobutaro Ban
Journal:  Nagoya J Med Sci       Date:  2014-08       Impact factor: 1.131

7.  Auto-antibodies against P/Q- and N-type voltage-dependent calcium channels mimicking frontotemporal dementia.

Authors:  Kyan Younes; Lauren A Lepow; Cynthia Estrada; Paul E Schulz
Journal:  SAGE Open Med Case Rep       Date:  2018-04-10

8.  Chronic Lymphocytic Inflammation with Pontine Perivascular Enhancement Responsive to Steroids (CLIPPERS) with Limbic Encephalitis.

Authors:  Yasuyuki Ohta; Emi Nomura; Keiichiro Tsunoda; Toru Yamashita; Yoshiaki Takahashi; Kota Sato; Mami Takemoto; Nozomi Hishikawa; Koji Abe
Journal:  Intern Med       Date:  2017-08-21       Impact factor: 1.271

9.  Comparison of relapsing polychondritis patients with and without central nervous system involvement: A retrospective study of 181 patients.

Authors:  Xiaoyu Cao; Lixiu Zhu; Huijuan Li; Li Jiang; Dong Xu; Jiuliang Zhao; Jiaxin Zhou; Fengchun Zhang; Yong Hou; Xiaofeng Zeng
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

Review 10.  Are onconeural antibodies a clinical phenomenology in paraneoplastic limbic encephalitis?

Authors:  Hongliang Zhang; Chunkui Zhou; Limin Wu; Fengming Ni; Jie Zhu; Tao Jin
Journal:  Mediators Inflamm       Date:  2013-07-25       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.